On Monday, in the course of current trade, Shares of Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA), dropped -5.36%, and is now trading at $17.50.
Momenta Pharmaceuticals, declared the appointment of Georges Gemayel, Ph.D. to its Board of Directors effective January 1, 2016. Dr. Gemayel has over 25 years of experience in the global biopharmaceutical industry counting administration and executive positions at biopharmaceutical companies such as Roche Labs, Genzyme and Altus Pharmaceuticals.
Dr. Gemayel has been a consultant for several biotechnology companies and venture capital funds since 2010. Preceding to that he was President and CEO of Altus Pharmaceuticals from 2008 to 2009. From 2003 to 2008, he was Executive Vice President at Genzyme Corporation where he was responsible for the company’s worldwide therapeutics businesses. From 1988 to 2003, he held progressively senior roles at Hoffmann La-Roche and Roche Labs. Dr. Gemayel presently serves on the Board of Directors of the publically listed companies Raptor Pharmaceutical Corp. and Supernus Pharmaceuticals and of Dimension Therapeutics, a privately owned company. He is Chairman of the Board of Directors of privately owned biotechnology companies Orphazyme, OxThera, and Enterome Bioscience. He formerly served on the Board of Directors of NPS Pharmaceuticals, Prosensa, Adolor Corporation, FoldRx, Epitherapeutics and Altus Pharmaceuticals.
Momenta Pharmaceuticals, Inc., a biotechnology company, focuses on developing generic versions of complex drugs, biosimilars, and novel therapeutics for oncology and autoimmune diseases.
During an Afternoon trade, Shares of JinkoSolar Holding Co., Ltd. (NYSE:JKS), climbed 3.02%, and is now trading at $22.55.
JinkoSolar Holding Co., Ltd. declared the official launch of the JinkoMX module series, incorporating a single chip optimizer from Maxim Integrated Products, Inc. (“Maxim”).
JinkoSolar has accomplished UL certification for this module series, which will generate more electricity than standard modules under most non-ideal real world conditions. JinkoSolar is the first PV module manufacturer offering mass production of this technology for the US solar market.
JinkoSolar Holding Co., Ltd., together with its auxiliaries, engages in the design, development, production, and marketing of photovoltaic products in the People’s Republic of China and internationally.
Shares of American Tower Corp (NYSE:AMT), climbed 0.43%, and is now trading at $90.38.
American Tower Corporation, declared that its Chairman, President and Chief Executive Officer, Jim Taiclet, spoke at the Goldman Sachs 24th Annual Communacopia Conference in New York City on Thursday, September 17, 2015 at 11:20 a.m. ET.
American Tower Corporation is a real estate investment trust. It invests in the real estate markets across the globe. The firm engages in leasing of space on multi-tenant communications sites to wireless service providers, radio and television broadcast companies, wireless data and data providers, government agencies and municipalities and tenants in a number of other industries.
Finally, T. Rowe Price Group Inc (NASDAQ:TROW), gained 0.53% Monday.
- Rowe Price Group, declared that its board of directors has elected H. Lawrence “Larry” Culp, Jr. and Alan D. Wilson to be independent directors of the company.
Mr. Culp was chief executive officer and president of Danaher Corporation from 2001 to 2014 and is now a senior advisor to the company. He serves as chair of the Board of Visitors and Governors for Washington College and as a member of the Board of Trustees of Wake Forest University. Mr. Culp recently joined the faculty of the Harvard Business School as a senior lecturer and in 2014 he ranked 38th on Harvard Business Review’s list of the 100 best-performing CEOs in the world.
Mr. Culp holds a Bachelor of Arts degree from Washington College and an M.B.A from Harvard Business School.
- Rowe Price Group, Inc. is a publicly owned asset administration holding company. The firm provides its services to individuals, institutional investors, retirement plans, financial intermediaries, and institutions. Through its auxiliaries, it launches and manages equity and fixed income mutual funds.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
